logo

Biotech Stocks Facing FDA Decision In April 2021

1 / 17
Q1 Scorecard of New Drug Approvals
Q1 Scorecard of New Drug Approvals

Four novel drugs were approved by the FDA in March taking the tally of new drug approvals in the first quarter of 2021 to 14. This compares with 11 new drug approvals in the first quarter of last year. In all, a total of 53 novel drugs were approved in 2020.

*Novel drugs are new molecular entities (NMEs) having chemical structures that have never been approved before.

Let's take a look at the companies that await a ruling from the FDA in April 2021.